Rankings
Pricing
Log In
Free Trial
JP-listed companies
Perseus Proteomics Inc.
Perseus Proteomics Inc.
JP:4882
Market cap
¥7.8B
P/E ratio
Add to your list
Add to your list
Back to summarized table
B
M
K
JPY
xbrli:pure
Annual
Quarterly
Download CSV
Income statement
Balance sheet
Cash flow
Mar 31,
2023
Mar 31,
2024
Profit (loss) before income taxes
-785
-1,103
Depreciation
6
3
Impairment losses
95
154
Interest income
-0
-0
Share issuance costs
-
6
Share-based payment expenses
31
41
Decrease (increase) in trade receivables
0
-4
Decrease (increase) in inventories
0
-1
Decrease (increase) in advance payments to suppliers
14
5
Increase (decrease) in accounts payable - other
22
1
Increase (decrease) in long-term deposits received
59
108
Other, net
-5
-42
Subtotal
-562
-832
Interest received
0
0
Income taxes paid
-2
-2
Income taxes refund
0
0
Net cash provided by (used in) operating activities
-564
-834
Purchase of property, plant and equipment
-164
-143
Purchase of intangible assets
-7
-16
Purchase of long-term prepaid expenses
-1
-0
Payments of guarantee deposits
-42
-
Proceeds from refund of guarantee deposits
-
9
Net cash provided by (used in) investing activities
-213
-150
Payments for issuance of shares
-
-0
Proceeds from issuance of shares resulting from exercise of share acquisition rights
-
63
Proceeds from issuance of share acquisition rights
-
1
Purchase of treasury shares
-0
-0
Net cash provided by (used in) financing activities
-0
64
Effect of exchange rate change on cash and cash equivalents
7
17
Net increase (decrease) in cash and cash equivalents
-770
-904